Bavarian Nordic
Kvistgaard · Founded 1994
About Bavarian Nordic
Bavarian Nordic is a industrial biotechnology company developing and producing novel vaccines for the treatment and prevention of life-threatening diseases with a large unmet medical need. The company's business strategy is focused in three areas: biodefence, cancer and infectious diseases.
Company Facts
- Founded: 1994
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 1,001 – 5,000
- Estimated revenue: $500K – $1M
- Total funding: $328.8M
- Funding stage: IPO
- Last round: Post-IPO Equity (Oct 2021)
- Ticker: cph:BAVA
- Website: bavarian-nordic.com
- Phone: (453) 326-8383
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/bavarian-nordic-70676 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.